pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-548f-1 |
Genomic Coordinates | chr10: 54607874 - 54607957 |
Synonyms | MIR548F-1, MIRN548F1, hsa-mir-548f-1, MIR548F1 |
Description | Homo sapiens miR-548f-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-548f-2 |
Genomic Coordinates | chr2: 212426263 - 212426360 |
Synonyms | MIR548F-2, MIRN548F2, hsa-mir-548f-2, MIR548F2 |
Description | Homo sapiens miR-548f-2 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-548f-3 |
Genomic Coordinates | chr5: 110513829 - 110513915 |
Synonyms | MIR548F-3, MIRN548F3, hsa-mir-548f-3, MIR548F3 |
Description | Homo sapiens miR-548f-3 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-548f-4 |
Genomic Coordinates | chr7: 147378017 - 147378121 |
Synonyms | MIR548F-4, MIRN548F4, hsa-mir-548f-4, MIR548F4 |
Description | Homo sapiens miR-548f-4 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-548f-5 |
Genomic Coordinates | chrX: 32641474 - 32641559 |
Synonyms | MIR548F-5, MIRN548F5, hsa-mir-548f-5, MIR548F5 |
Description | Homo sapiens miR-548f-5 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-548f-3p | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 59| AAAAACUGUAAUUACUUUU |77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LMLN | ||||||||||||||||||||
Synonyms | GP63, INV, IX14, MSP | ||||||||||||||||||||
Description | leishmanolysin like peptidase | ||||||||||||||||||||
Transcript | NM_001136049 | ||||||||||||||||||||
Other Transcripts | NM_033029 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LMLN | |||||||||||||||||||||
3'UTR of LMLN (miRNA target sites are highlighted) |
>LMLN|NM_001136049|3'UTR 1 GAATGGAAAAGTGGATCTTCAAGATATTCTTTTATGTTATGTTCTTGTGAACAAAGCACAAAGTTTGAGTGAGTGCCAAC 81 CTATGCAGATGGTAGAAGTGGCATTCCTGGCTTTGGCTTGGAAGAATTGACGACCATCAGACCTTGAAGCAGAACTTCAC 161 AGCAGCCTGTCCTCATCAGCAACCCAACCACCTTCATCAGCAACCCAACCACCTTCATCAGCAACCCAACCACCTCGTCA 241 GCAACCCAACCACCTCGTCAGCAACCCAACCACCTCGTCAGCAACCCAGCCACCTTCATCAGCAACCCAACCACCTCATC 321 AGCAACCCAGCCACCTTCATCAGCAACCCAACCACCTCATCAGCAAACCAACCACTTTCATCTGCAACCCAACCACTTTC 401 ATCAGCAACTCAACACCTTCATCTGCAACCCAACCACCTTCATCAGCAAACCAACCACCTTCTTCAGCAACCCAACCACC 481 TCATCTTGGAGAAGGAGAAGGAACTGCAAGCCACCAAGTCTTCATTTTTCAGGGTTTGTAATCTTCCCAAAGTTTTCCTT 561 TGAAAATAGGATAATGGGTGGAATTTTCAGAGTGATTACATACCTCAACATTTTTATTAACATACAACAATGGGAAAGTT 641 CATCATCCATATACTGCAGTCACTTAAACAACAGCCAATTATTGCAAGATTAGAATTGGAGATCTTGTCCTCAAAAGTAT 721 AAATTGTCCTTTGAGTTATAGAAAATAATGGAATTGGGATTTCTACATATCATTATTATACCTATTTTAAATTTAATGGC 801 AGCCAGGCATGGTTCCAGCTACTTGGGAGGCTGAGGCAGGAGGATCGCTTGAGCCCAGGAGTTCAAGGCTGCAGTGAGCT 881 ATGATTGCACCACTGTATTCCAGCCTGCACGATAGAGTTAGACCCTGTATCTTAAAAAAAAAAAAATTAATGGCTGGTAT 961 ATAGTAAACTTAATTCACTGTTCCCATTGTTCTAAAGAATTTTTTTAAATAATGTTTCATTAAATCTTATGATTTAACCG 1041 TGCTTGCCCTTTTTGCCAGCTATGTGGCAGTTTACGGCAGAACTGCTGTCAGTGTGCTGGTAGCCCTCTATTCATCCCTC 1121 CTCAGAGCCCAGCTTCCAGAACTGCTATCACTGTGCTGGTAGCCCTCTGTATTCATCCCTCTTCAGAGCTCAGCTTCTGG 1201 TTGTATTCTCCATGAGTTTAATAATGACATGAAAAAATGTGGAAGCCGAGAGAGTAAAATACTCTGCCCTGTAAAAACAT 1281 GGAAGACATGCAAACAGAAAAAAAATAATTGTATTGTTTTAGATAATACTTAAGACAACTGTGAAACAACAAAAACACAA 1361 CTATTCCTTTGTGACCGATGAAGATAAAAAGAAATTCTGGTAAAGACGGGTATGCAGTTTTTTAAAATGGGTTAAGAAAT 1441 TGTTGCAGAAGAATTTCTAACATCTGAAAATGGTTTTATGTTTAAGAAGGATGGTCTGAATTGTGTACTAATAGCAAGGT 1521 ATAAGTTTGGTGTAGAGCCTATCCAGTAGCGTCCACTGTACCACTTTTAAGTAAGACTCAGTCCACAGAAGCTGGAAGAT 1601 TGCCTTCGCTTTAAATATCCTTTACCTTCTGCATTTGACACTCCTCCTGTTACTACATAGATTCCGGTCCCCAGAAGCAA 1681 TTTTACACTGGTACTAGAGCTTACCAGCCCCATTTAGTAATTTTTAATGGCTAGATGAGGTTTAACAAGAATATGAAAAG 1761 AAAAAAGAAAAAATATATTCATGAATGATAGGCGATGCCCATTCTTTCTCTCAAGCTAATGAAGTCCTATGGCATTCTAA 1841 CCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCC 1921 ATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTACTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCC 2001 TCCTACTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTACTCCTCCATGGCATTGTAACCACAACCCT 2081 CGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGT 2161 AACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTATTCCTCCA 2241 TGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCT 2321 TCTGTTCCTCCTTTCCTCGTCCTTCCCTGCTTTTCGTCCATTCAGCATATAGCTATTCAGTACTCCATTGAAGAAATTAT 2401 GCTAAGTGAGCAAAGCAACATAATTACTAAGAATTAATTCTGATTATTTGGCACTAGAGCCAACAGCAACCCCAGCACAG 2481 AGGAAAGTCGCTTTTTTTTCAAATGCATAAATTTAAAGTATGTATTTGCATGCAGTTTTAAATGGGAGGTATTTGTCATT 2561 GTGAAAAGCTGGGAATCTCAAACATAGTCAACTTAACTAAAAAGAAGCTAATACAGGTTGAGCATTCCTAATCCAAAAAT 2641 CCAGAATCCAAATTGCTCCAAAATCTGAAACTTTCTGAATGCTGACCTGATACTACAAGTAGAAAATTCCACATACAAGT 2721 ACTTAACACAAACTTTGTTTCATGCACAAACTACTAAAAATATTGTATAAAATTACCTTCAGGCAGTGTGTGTAGTTATA 2801 TATGAAACATGAATTTCATGTTTAGACTTGGGTCCATGCCCAAGATACCTCATTAGGTATCTGTAAATATCCGAAATCCA 2881 AAAAAAAGTCTGAAATCTGAAACACTTCTGGTCCCAAGCATTTCAGTAAGTGATGCTCAACCTGCGTAATGGTCTGCGGG 2961 CCAGTGCTCATTTTCTGCCTATGTTGTACATACTTTAAATTGTGTAAATTAAAAGTCAAAGCAAAGAGTCTATTTTTAAA 3041 GAAACTTACAATAATCTAAACATATACTTCTTATGATTATGAATCATCCTGCAAAGCTGAATGAAGAATTTTACCAAAAA 3121 TACAATGAATTAATCATATATTTGAGAGTCACAGTGATAGGTTCGACTATATTTTGACTGTTGTGTAGTGGCACCGTTTA 3201 GGTAGTATTGTTTCTGAGCATGGTGCTTTTTATACTTGAAATATATTTTTGCTTTATTTTTTATTGATATAATTATATTT 3281 GCACTAATGGCTTTCTGAAGAAAATATTATAGATGACATTTTTTGTATATATATTTATTAAGCTTGGGAACCTGGTCGCC 3361 CAGTGTTTTCTCTGGACAAATGTGAAACTGGATAAAGTATGGATAAAGTCTTGAGTTCCTCAGGGTAACTGTGTTGATGT 3441 CTCCCGTCCTCTTCAGTAAGGCTTGAATATGATTTTACTCATCATTGATTCTGCATAGTGTACCCAGCAAGACTTAGAAG 3521 GACACTGAACCTGTCAGAGATTTTAAGAGGCACATTTTAGTCACTTTGAATATGGTAGTGGTGGGCGCGGTGACTGAAGC 3601 CTGTAATCTCAGCACTTCGGGAGGCCAAGGCAAGCAGATCACGAGATCAGGAGTTTGAGGTTACAGTGAGCTGATCGCAC 3681 CACTGCACTGCAGCCTGGATGACAGAGTGAGACTTTCTTGGGAAAAAAAAAAATGACAGTGAAGCAGACTTTTAGAATCC 3761 GAGATGTCATTGCAGAATTATTGGTATAAAATTCAGCTGCAAAGTGAAGAAATTGAAATGGCCCACACGTTGATATCCTG 3841 TGGCAGGTTATACCCTTCATGTTAGCAAAGACGAAGCCACGTCGCTGTGTTAAGAGGGACAGGCTGGGCCGGCTGCAGCT 3921 GTAGTGGAAGTGAGGGACACAGGGAAGGAATGGGGAGCAGCAATTTGGGGACAGTAGACTGGAGTCACTTTCTGACTCAA 4001 AAAGGGTCAAGTACTTATTAAAAACTATCTTGGTTTTCTGTTCAGACTTAGGCTCATTTTGATCATTTTAAGGTCCCAGT 4081 TGTCAAAAATATCAAGTGAATTTGTCTCAGGTTTTCAGAAACAAAATTTACAGGAAGGAAGCAAAAGCCATGTCAGTAGC 4161 CTTGAGCTGACAGCTTTAAAGAAACTGGCAAACAGGTAGGTTGTCCTCATATAGATCCTTCCAGTATTCTGAAAAACATC 4241 CTTTTATTTCTTAAAACCAGTAACCCTTACATTTTTCCTATAGGATAGTTATTTTTGTTGAGATCAAATAGACATTCTAT 4321 AAATGTTATAAATTATGCTTGCAGTTACTCAGCCTATCTAGGCTTAAGGTTTATCAATATTTGAAGTTGAAACATCATCT 4401 TATGAGGTTTAGTTTTAGGAAGATAAATAAATATATCAAAGTATTTCATAAAGTTGTATCAATGTTCCTTCTAACATTAG 4481 AAGACTTACTGACTGAGGCCATCTGTGAACGACTAGGTGATCTCAGAATCCTTCCAGCTCTAATACCCTCTGACTAACAC 4561 TCACCCAGAATTGCTGTCTGTGCTGGCTGTGATCTGCCTCCAGGAGCATACGCCATCCTGCGTGCTGTGTCCATCACAGT 4641 GTCTGTGCTCGGTGCCTTACCACTGTCCGTGTCCTTGGACGCTGACTGGACAGAGAGGAGCCTGTCTCTCAGGGCACATG 4721 AGTCGTCGTGGCAGGAGGAGACGGGCCTCAGTCACAGTGTCACAGACCCTTGTCACAGTGGACACTAGTCATTCCTGCCA 4801 TGTCCTTGCAGCCCAGGAGGACTAAAAAGATTTTAATGAAGTCTGTGTTACTCATTCTGAAGAAAAGAACTTACCTGAGA 4881 GGAGTAATATTTTTTTAATATATATTGGGTCAGGGACAGGGATGGAGTGGTTGTTTTATGTTTACATTTTTAATAAGTAA 4961 AATAGAAGATTTAAGAACTAATATTTATGGTATTGAACTTTAAGTGTGATATATTCCTTAGAAAAACACAACTTTAATAA 5041 AAATGGAAACTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 89782.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000330198.4 | 3UTR | CAUGCAGUUUUAAAUGGGAGGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
153 hsa-miR-548f-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT075032 | DYNC1LI2 | dynein cytoplasmic 1 light intermediate chain 2 | 2 | 2 | ||||||||
MIRT076422 | PAFAH1B1 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 2 | 2 | ||||||||
MIRT077732 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT097425 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 2 | ||||||||
MIRT099605 | ID4 | inhibitor of DNA binding 4, HLH protein | 2 | 4 | ||||||||
MIRT105530 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT109834 | MID1IP1 | MID1 interacting protein 1 | 2 | 8 | ||||||||
MIRT132952 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT134169 | KLHL42 | kelch like family member 42 | 2 | 4 | ||||||||
MIRT138721 | MPP5 | membrane palmitoylated protein 5 | 2 | 2 | ||||||||
MIRT187755 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT208054 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT222029 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT243457 | LMLN | leishmanolysin like peptidase | 2 | 2 | ||||||||
MIRT266062 | FJX1 | four jointed box 1 | 2 | 6 | ||||||||
MIRT279835 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT285122 | TERF2IP | TERF2 interacting protein | 2 | 6 | ||||||||
MIRT323906 | TMEM245 | transmembrane protein 245 | 2 | 2 | ||||||||
MIRT325430 | CKS2 | CDC28 protein kinase regulatory subunit 2 | 2 | 2 | ||||||||
MIRT338909 | HMGN2 | high mobility group nucleosomal binding domain 2 | 2 | 6 | ||||||||
MIRT350498 | MRGBP | MRG domain binding protein | 2 | 6 | ||||||||
MIRT405877 | CALM1 | calmodulin 1 | 2 | 2 | ||||||||
MIRT442081 | NDRG1 | N-myc downstream regulated 1 | 2 | 2 | ||||||||
MIRT442371 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT442397 | ILDR1 | immunoglobulin like domain containing receptor 1 | 2 | 2 | ||||||||
MIRT444255 | INTS8 | integrator complex subunit 8 | 2 | 2 | ||||||||
MIRT444875 | ISPD | isoprenoid synthase domain containing | 2 | 2 | ||||||||
MIRT445407 | PTCHD1 | patched domain containing 1 | 2 | 4 | ||||||||
MIRT445493 | HMGN4 | high mobility group nucleosomal binding domain 4 | 2 | 2 | ||||||||
MIRT446136 | ST6GAL2 | ST6 beta-galactoside alpha-2,6-sialyltransferase 2 | 2 | 2 | ||||||||
MIRT446261 | GRAMD1C | GRAM domain containing 1C | 2 | 2 | ||||||||
MIRT446353 | EML6 | echinoderm microtubule associated protein like 6 | 2 | 2 | ||||||||
MIRT446403 | SNX1 | sorting nexin 1 | 2 | 2 | ||||||||
MIRT446826 | STK17A | serine/threonine kinase 17a | 2 | 2 | ||||||||
MIRT447222 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT447705 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT448248 | ZNF774 | zinc finger protein 774 | 2 | 2 | ||||||||
MIRT448819 | FKBP1A | FK506 binding protein 1A | 2 | 4 | ||||||||
MIRT449060 | ZNF558 | zinc finger protein 558 | 2 | 2 | ||||||||
MIRT449668 | ZNF451 | zinc finger protein 451 | 2 | 2 | ||||||||
MIRT449974 | ZNF555 | zinc finger protein 555 | 2 | 2 | ||||||||
MIRT450476 | TRMT5 | tRNA methyltransferase 5 | 2 | 4 | ||||||||
MIRT450483 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 2 | ||||||||
MIRT467980 | SKIL | SKI like proto-oncogene | 2 | 4 | ||||||||
MIRT470733 | POFUT1 | protein O-fucosyltransferase 1 | 2 | 2 | ||||||||
MIRT475012 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 8 | ||||||||
MIRT490478 | FEM1C | fem-1 homolog C | 2 | 2 | ||||||||
MIRT497368 | DIRAS2 | DIRAS family GTPase 2 | 2 | 2 | ||||||||
MIRT497561 | PRLR | prolactin receptor | 2 | 2 | ||||||||
MIRT497943 | ABCB7 | ATP binding cassette subfamily B member 7 | 2 | 2 | ||||||||
MIRT498014 | ZBTB20 | zinc finger and BTB domain containing 20 | 2 | 2 | ||||||||
MIRT498206 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT502637 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 8 | ||||||||
MIRT505633 | SLC16A1 | solute carrier family 16 member 1 | 2 | 6 | ||||||||
MIRT512261 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 6 | ||||||||
MIRT518247 | SCIN | scinderin | 2 | 4 | ||||||||
MIRT520483 | TRIM13 | tripartite motif containing 13 | 2 | 4 | ||||||||
MIRT521196 | SBNO1 | strawberry notch homolog 1 | 2 | 6 | ||||||||
MIRT522764 | LARP1 | La ribonucleoprotein domain family member 1 | 2 | 4 | ||||||||
MIRT525021 | ABHD13 | abhydrolase domain containing 13 | 2 | 4 | ||||||||
MIRT525100 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT525268 | CD226 | CD226 molecule | 2 | 4 | ||||||||
MIRT528662 | FUNDC2 | FUN14 domain containing 2 | 2 | 2 | ||||||||
MIRT529353 | SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 2 | 2 | ||||||||
MIRT529651 | ZNF81 | zinc finger protein 81 | 2 | 2 | ||||||||
MIRT529815 | TMLHE | trimethyllysine hydroxylase, epsilon | 2 | 2 | ||||||||
MIRT530316 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT532775 | LDHD | lactate dehydrogenase D | 2 | 2 | ||||||||
MIRT533888 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 2 | ||||||||
MIRT535657 | NLN | neurolysin | 2 | 4 | ||||||||
MIRT536351 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT538089 | DGKE | diacylglycerol kinase epsilon | 2 | 2 | ||||||||
MIRT538118 | DDX6 | DEAD-box helicase 6 | 2 | 2 | ||||||||
MIRT538950 | BMP2K | BMP2 inducible kinase | 2 | 2 | ||||||||
MIRT539086 | ARNTL | aryl hydrocarbon receptor nuclear translocator like | 2 | 4 | ||||||||
MIRT539374 | ADSS | adenylosuccinate synthase | 2 | 6 | ||||||||
MIRT539860 | DNTTIP2 | deoxynucleotidyltransferase terminal interacting protein 2 | 2 | 4 | ||||||||
MIRT539976 | SPRY1 | sprouty RTK signaling antagonist 1 | 2 | 2 | ||||||||
MIRT541264 | GPC4 | glypican 4 | 2 | 4 | ||||||||
MIRT543374 | CYB5B | cytochrome b5 type B | 2 | 2 | ||||||||
MIRT543472 | PARP15 | poly(ADP-ribose) polymerase family member 15 | 2 | 2 | ||||||||
MIRT543685 | HHLA1 | HERV-H LTR-associating 1 | 2 | 2 | ||||||||
MIRT543877 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT544021 | KLRC3 | killer cell lectin like receptor C3 | 2 | 2 | ||||||||
MIRT544119 | TTLL11 | tubulin tyrosine ligase like 11 | 2 | 4 | ||||||||
MIRT545311 | SPC25 | SPC25, NDC80 kinetochore complex component | 2 | 2 | ||||||||
MIRT545769 | HS3ST1 | heparan sulfate-glucosamine 3-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT545991 | XKR4 | XK related 4 | 2 | 2 | ||||||||
MIRT546078 | VEZF1 | vascular endothelial zinc finger 1 | 2 | 2 | ||||||||
MIRT546717 | RNPS1 | RNA binding protein with serine rich domain 1 | 2 | 4 | ||||||||
MIRT548964 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT552133 | MED10 | mediator complex subunit 10 | 2 | 2 | ||||||||
MIRT553941 | STARD3NL | STARD3 N-terminal like | 2 | 2 | ||||||||
MIRT554148 | SLX4 | SLX4 structure-specific endonuclease subunit | 2 | 2 | ||||||||
MIRT555009 | RAB33B | RAB33B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT555495 | PNRC2 | proline rich nuclear receptor coactivator 2 | 2 | 2 | ||||||||
MIRT555651 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT557631 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT557989 | FAM160B1 | family with sequence similarity 160 member B1 | 2 | 2 | ||||||||
MIRT558838 | CDCA4 | cell division cycle associated 4 | 2 | 4 | ||||||||
MIRT563344 | RPLP0 | ribosomal protein lateral stalk subunit P0 | 2 | 2 | ||||||||
MIRT563902 | RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | 2 | 2 | ||||||||
MIRT564263 | DEPDC1B | DEP domain containing 1B | 2 | 2 | ||||||||
MIRT565516 | SOX4 | SRY-box 4 | 2 | 2 | ||||||||
MIRT565847 | SCML2 | Scm polycomb group protein like 2 | 2 | 2 | ||||||||
MIRT567174 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT573142 | ABT1 | activator of basal transcription 1 | 2 | 2 | ||||||||
MIRT573248 | ZBTB46 | zinc finger and BTB domain containing 46 | 2 | 2 | ||||||||
MIRT573740 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT573983 | DDX21 | DExD-box helicase 21 | 2 | 2 | ||||||||
MIRT574478 | RPS16 | ribosomal protein S16 | 2 | 2 | ||||||||
MIRT608343 | ZRANB1 | zinc finger RANBP2-type containing 1 | 2 | 2 | ||||||||
MIRT609782 | NHSL1 | NHS like 1 | 2 | 2 | ||||||||
MIRT612536 | RSF1 | remodeling and spacing factor 1 | 2 | 2 | ||||||||
MIRT613193 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT617539 | GRK4 | G protein-coupled receptor kinase 4 | 2 | 2 | ||||||||
MIRT617779 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT620252 | PCK1 | phosphoenolpyruvate carboxykinase 1 | 2 | 2 | ||||||||
MIRT621740 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT628105 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT629471 | CRLS1 | cardiolipin synthase 1 | 2 | 6 | ||||||||
MIRT638139 | TTC26 | tetratricopeptide repeat domain 26 | 2 | 2 | ||||||||
MIRT641039 | PITPNB | phosphatidylinositol transfer protein beta | 2 | 2 | ||||||||
MIRT642453 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT643159 | NCK1 | NCK adaptor protein 1 | 2 | 2 | ||||||||
MIRT643260 | ZNF566 | zinc finger protein 566 | 2 | 2 | ||||||||
MIRT649827 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT651199 | ZNF280B | zinc finger protein 280B | 2 | 2 | ||||||||
MIRT654633 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | 2 | 2 | ||||||||
MIRT656633 | LRRC15 | leucine rich repeat containing 15 | 2 | 2 | ||||||||
MIRT660588 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT660865 | AFAP1 | actin filament associated protein 1 | 2 | 2 | ||||||||
MIRT664141 | ATP6V1G3 | ATPase H+ transporting V1 subunit G3 | 2 | 2 | ||||||||
MIRT666130 | SPATS2L | spermatogenesis associated serine rich 2 like | 2 | 2 | ||||||||
MIRT666391 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 2 | ||||||||
MIRT667143 | NT5DC3 | 5'-nucleotidase domain containing 3 | 2 | 2 | ||||||||
MIRT673834 | SPPL2A | signal peptide peptidase like 2A | 2 | 2 | ||||||||
MIRT675539 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT693450 | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 2 | 2 | ||||||||
MIRT694852 | KRT80 | keratin 80 | 2 | 2 | ||||||||
MIRT696047 | KCNK6 | potassium two pore domain channel subfamily K member 6 | 2 | 2 | ||||||||
MIRT696951 | CERK | ceramide kinase | 2 | 2 | ||||||||
MIRT697839 | UBL3 | ubiquitin like 3 | 2 | 2 | ||||||||
MIRT700270 | RAP2B | RAP2B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT702733 | INSIG1 | insulin induced gene 1 | 2 | 2 | ||||||||
MIRT705310 | AVL9 | AVL9 cell migration associated | 2 | 2 | ||||||||
MIRT705325 | ATP2A2 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 2 | 2 | ||||||||
MIRT707735 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT711798 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT713736 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT715766 | SKA2 | spindle and kinetochore associated complex subunit 2 | 2 | 2 | ||||||||
MIRT719186 | KCNS2 | potassium voltage-gated channel modifier subfamily S member 2 | 2 | 2 | ||||||||
MIRT719478 | PECR | peroxisomal trans-2-enoyl-CoA reductase | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|